Home | Volume 55 | Article number 119

Research

Prevalence, knowledge, and factors associated with hepatitis B vaccination among medical students in Hargeisa, Somaliland

Prevalence, knowledge, and factors associated with hepatitis B vaccination among medical students in Hargeisa, Somaliland

Adnan Abdilahi Matan1,&, Jama Mohamed2, Hussein Abdi Ali1

 

1Faculty of Health Sciences, New Generation University, Hargeisa, Somaliland, 2Faculty of Statistics and Data Science, College of Business, Economics and Statistics, University of Hargeisa, Hargeisa, Somaliland

 

 

&Corresponding author
Adnan Abdilahi Matan, Faculty of Health Sciences, New Generation University, Hargeisa, Somaliland

 

 

Abstract

Introduction: hepatitis B virus (HBV) remains a major public health concern, particularly among healthcare students due to occupational exposure risks. This study assessed the prevalence, knowledge, and factors associated with hepatitis B vaccination among medical students in Hargeisa, Somaliland.

 

Methods: a cross-sectional survey was conducted among 183 students from multiple medical departments across three universities. Data on sociodemographic characteristics, knowledge of HBV transmission and prevention, vaccination status, and associated factors were collected and analyzed using descriptive statistics (frequencies and percentages) and inferential analysis (binary logistic regression). Data were exported from Kobo Toolbox and analyzed using STATA version 17.

 

Results: the majority of participants were aged 19-25 (84.15%), female (64.48%), and single (82.51%). Knowledge of HBV transmission and prevention was generally high, with over 95% correctly identifying major transmission routes and prevention methods. The overall prevalence of hepatitis B vaccination was 67.2% (95% CI: 60.1%-73.6%). However, only 42.28% had completed all three recommended doses. Key barriers to vaccination included vaccine cost, unavailability, and fear of side effects. Logistic regression revealed that pharmacy students (aOR: 0.01, 95% CI: 0.00-0.65; p = 0.030), sixth-year students (AOR = 0.01, p = 0.043), and those never tested for HBV (AOR < 0.001, 95% CI: 0.00 - 0.88;p < 0.001) were significantly less likely to be vaccinated.

 

Conclusion: while the majority of medical students demonstrated good knowledge of HBV and moderate vaccination uptake, critical gaps remain in vaccine completion and access. Targeted strategies, particularly for pharmacy students, final-year students, and untested individuals, are needed to improve full vaccination coverage and reduce HBV transmission risks in healthcare settings.

 

 

Introduction    Down

Hepatitis B virus (HBV) is a major global public health concern, causing both acute and chronic liver disease. In 2022, an estimated 254 million people were living with HBV infection, though the number of new infections decreased from 3 million in 2019 to 2.2 million in 2022 [1]. Hepatitis B virus was responsible for over 1.3 million deaths in 2022, primarily from cirrhosis and hepatocellular carcinoma (HCC) [1]. Unlike some other infectious diseases, HBV is entirely vaccine-preventable, and the World Health Organization (WHO) has set a target to eliminate viral hepatitis as a public health threat by 2030 [2]. The global distribution of HBV varies widely by region. High endemicity areas, where prevalence exceeds 8%, include much of sub-Saharan Africa and the Western Pacific [3,4]. Moderate prevalence is seen in parts of Asia, the Middle East, and Eastern Europe, while low prevalence is found in North America, Northern Europe, Australia, and parts of Latin America [5,6]. In 2022, the African region recorded the highest prevalence rate globally at 5.4% [7]. In China alone, more than 75 million people were positive for HBV surface antigen in 2020, and HBV accounted for up to 84.4% of HCC cases [8,9]. Healthcare workers (HCWs) are at increased risk of HBV due to occupational exposure to blood and body fluids. An estimated 7% of HCWs in Africa have been infected with HBV at work [10]. In the United States, a broader national report covering adult vaccination found that 67.2% of HCWs had completed the full three-dose HBV vaccine series [11]. However, vaccination coverage among HCWs is much lower in low- and middle-income countries, ranging from 18% to 39%, compared with 67% to 79% in high-income countries [12-14]. Medical students are particularly vulnerable during clinical training because of limited experience, inconsistent use of universal precautions, and lower awareness of infection control measures [15-17].

Multiple factors influence HBV vaccination uptake among HCWs and medical students. Common barriers include lack of awareness, fear of side effects, vaccine cost, unavailability, and absence of pre-vaccination screening [18,19]. Knowledge and attitudes toward HBV also play a critical role; studies in Ethiopia and Sudan have shown that while the majority of students recognize vaccination as an effective preventive measure, a substantial proportion remain unvaccinated [20,21]. Similar trends are reported in India [22], Nigeria [23], and South Africa [24], where coverage rates remain below optimal levels. In sub-Saharan Africa, HBV prevalence ranges from 5% to 8% [4]. In Ethiopia, the prevalence in the general population is estimated at 6.9% [25,26]. Somalia and Somaliland face particular challenges in HBV control due to decades of conflict that have weakened healthcare infrastructure. Since 2013, HBV vaccination has been included in the national immunization program for children under five years [27]. However, coverage among HCWs remains low; one Somali study reported that only 16.4% had received the full three-dose vaccination [27]. In Ethiopia, the figure was even lower for health science students, at just 5.8% [28]. Despite the high burden of HBV in Africa and the recognized occupational risks for HCWs, there is little published evidence on HBV vaccination coverage and associated factors among medical students in Somaliland. Understanding vaccination status and its determinants in this group is critical for designing targeted interventions to protect future healthcare providers and reduce HBV transmission. This study, therefore, aims to determine the prevalence of HBV vaccination and identify associated factors among medical students in Hargeisa, Somaliland.

 

 

Methods Up    Down

Study design and settings: this study employed an institution-based cross-sectional design and was conducted from December 2024 to April 2025 in Hargeisa, the capital city of Somaliland. Three universities with medical and health faculties, New Generation University, the University of Hargeisa, and Edna Adan University, were included. Hargeisa is located at an altitude of approximately 1,334 meters above sea level and is bordered by Ethiopia to the southwest, Gabiley to the northwest, and Berbera to the east. These institutions were purposively selected as they host the largest number of medical and health sciences students in the region.

Study population: the study population consisted of undergraduate medical and health sciences students enrolled in the departments of medicine, pharmacy, nursing, midwifery, medical laboratory sciences, dentistry, and clinical officer training. Students from these departments were selected because of their direct and frequent exposure to patients during hospital and clinical training. Exclusion criteria included: i)First-year students, as they had not yet been exposed to clinical training; ii) students who declined to participate; iii) students who were absent during the data collection period.

Sample size determination and sampling procedure: the sample size was calculated using the single population proportion formula, assuming a 95% confidence interval, 5% margin of error, and an estimated prevalence of HBV vaccination of 33.4% (based on a previous study conducted among health sciences students in Mogadishu) [18]. This yielded a sample size of 174 students, and after adjusting for a 5% non-response rate, the final sample size was set at 183 participants. Participants were recruited using a voluntary sampling technique, whereby eligible students who consented to take part were enrolled until the required sample size was achieved.

Data collection tools: data were collected using a structured self-administered questionnaire (SAQ), developed in English and pre-tested on a small group of students outside the study setting to ensure clarity and consistency. The questionnaire comprised four sections: i) sociodemographic characteristics (age, sex, marital status, year of study, and monthly income); ii) Knowledge of HBV transmission and prevention (routes of infection, preventive measures, and awareness of the vaccine); iii) vaccination status (fully vaccinated with three doses, partially vaccinated, or not vaccinated); iv) Barriers to vaccination (cost, availability, fear of side effects, and lack of screening). Data collection was facilitated using Kobo Toolbox, an open-source digital platform that enhances accuracy and efficiency in survey administration, management, and visualization.

Statical analysis: completed questionnaires were checked for accuracy and completeness, and data were exported from Kobo Toolbox and analyzed using STATA version 17. Summary statistics (frequencies and percentages) and visualizations were used to summarize participant characteristics, knowledge levels, and vaccination status. Multivariable logistic regression analysis was conducted to identify factors independently associated with HBV vaccination. Adjusted odds ratios (AORs) with 95% CIs were reported, and a significance level of p < 0.05 was used to determine statistical significance.

Ethical consideration: ethical clearance was obtained from the New Generation University Research Ethics Committee (NGUREC) with Ref. No. NGU/12/7086/24. Written informed consent was obtained from all participants after explaining the purpose of the study, confidentiality of responses, and voluntary nature of participation. No personal identifiers were collected to ensure anonymity, and data were stored securely with access restricted to the research team.

 

 

Results Up    Down

Sociodemographic and academic characteristics of the study participants: a total of 183 students with a medical background participated in the study. The majority (84.15%) were aged 19-25 and females constituted a higher proportion (64.48%) compared to males (35.52%). More than half of the respondents (51.91%) were employed in the medical field, while 35.52% were unemployed. The most represented university departments were Midwifery (20.77%) and Nursing (20.22%). Most students were in their third (30.60%) or fourth year (29.51%), and a significant proportion (61.75%) reported a monthly income of less than $100. The majority (82.51%) were single, and nearly half (48.09%) attended Edna Adan University (Table 1).

Knowledge of hepatitis B virus transmission and prevention among student participants: all participants were assessed on their knowledge of HBV transmission and prevention. All participants had good knowledge regarding hepatitis B virus transmission and prevention. Nearly all respondents recognized transmission via blood/body fluids (98.36%) and needle sticks (99.45%), while 86.34% acknowledged mother-to-child transmission. Over 95% knew HBV affects all age groups and can be diagnosed through laboratory tests. Prevention knowledge was high for vaccination (96.72%) but slightly lower for PPE use (89.62%) and avoiding unsafe sex (88.52%). Gaps persisted in awareness of perinatal transmission (86.34%), avoiding unsafe sex (88.5%), and prevention by PPE use (89.62%) (Table 2). The prevalence of hepatitis B vaccination (at least one dose) among students is 67.2%, as illustrated in Figure 1. Based on a sample size of 183 students, the 95% confidence interval for this proportion is 60.1% to 73.6%, indicating that the true vaccination coverage in the broader student population is likely within this range. Despite the relatively high uptake, 32.8% of students remain unvaccinated, suggesting a need for enhanced awareness and access to the vaccine. Reasons for not being vaccinated against hepatitis B shows the reported reasons for not receiving the Hepatitis B vaccine. The most frequently cited reason was "Other reasons" (n = 23), indicating that a substantial portion of respondents had explanations not captured by the predefined categories. These reasons may include perceived low personal risk, limited access to vaccination sites, religious or cultural beliefs, or simple forgetfulness. Such findings highlight the importance of exploring context-specific barriers beyond the commonly recognized ones like cost and fear of side effects. Among the specific barriers, the most common were cost-related concerns ("The vaccine is too expensive", n = 8), fear of vaccine side effects (n = 7), lack of time (n = 7), and unavailability of the vaccine (n = 7). A smaller number of individuals indicated mistrust in vaccine quality (n = 3), lack of knowledge about where to go (n = 2), or not believing vaccination is important (n = 2). Only one participant reported being unaware of the hepatitis B vaccine entirely Figure 1. The distribution of the number of hepatitis B vaccine doses received among those who received at least one dose. The majority (42.28%) received all three recommended doses, indicating a relatively high completion rate. However, a significant proportion of individuals received only one dose (29.27%) or two doses (28.46%) Figure 2.

The factors associated with hepatitis B vaccination: a binary logistic regression was used to assess the factors associated with hepatitis B vaccination. The results indicated that students in the pharmacy department had significantly lower odds of vaccination (OR = 0.01, 95% CI: 0.00-0.65, p= 0.030) compared to medical students, while sixth-year students also had significantly reduced odds (OR = 0.01, 95% CI: 0.00-0.88, p = 0.043) relative to second-year students. Additionally, those who had never been tested for hepatitis B had nearly zero odds of vaccination (OR < 0.001,0.00-0.88 p < 0.001). No other demographic, occupational, or academic factors showed statistically significant associations with vaccination status. These findings suggest that targeted interventions may be needed for pharmacy students, advanced-year students, and individuals who have not undergone hepatitis B testing to improve vaccination rates (Table 3).

 

 

Discussion Up    Down

The findings of this study highlight both encouraging and concerning aspects of hepatitis B virus (HBV) knowledge and vaccination uptake among medical students in Somaliland. The high level of awareness regarding HBV transmission routes, such as exposure to blood, needlesticks, and sexual contact, reflects effective foundational education in medical training programs. Over 95% of participants correctly identified key preventive measures, including vaccination and personal protective equipment (PPE) use, suggesting that theoretical knowledge is well-disseminated. However, gaps in awareness of perinatal transmission (86.34%) and prevention through safe sex practices (88.52%) indicate areas where targeted educational interventions could further strengthen knowledge. These findings align with studies from Iraq and Nigeria, where knowledge gaps persist despite overall high awareness [29,30]. Despite the high level of knowledge, the vaccination uptake rate of 67.2% remains suboptimal, particularly given the occupational risks faced by healthcare students. The fact that only 42.28% of participants completed all three recommended doses is concerning, as incomplete vaccination leaves individuals vulnerable to infection. Similar low completion rates have been reported in studies from Ethiopia and Vietnam, where cost, accessibility, and lack of follow-up systems were major barriers [28,31]. The primary barriers identified in this study, such as vaccine cost, unavailability, and fear of side effects, underscore systemic issues in healthcare infrastructure that must be addressed through policy interventions, such as subsidized vaccination programs and institutional mandates for HBV immunization prior to clinical rotations.

The logistic regression analysis revealed significant disparities in vaccination rates among different student groups. Pharmacy students and sixth-year students were markedly less likely to be vaccinated compared to their peers, which may reflect differences in departmental curricula, clinical exposure timing, or perceived risk. Similar disparities have been observed in Japan, where pharmacy students had lower vaccination rates than medicine students [32], possibly due to underestimation of occupational exposure. Additionally, students who had never been tested for HBV had nearly zero odds of vaccination, suggesting that HBV screening could serve as a critical entry point for vaccination promotion. These findings call for tailored interventions, such as integrating HBV vaccination into departmental requirements and ensuring that testing and immunization are routinely offered at university health services. The socioeconomic factors influencing vaccination uptake also warrant attention. While monthly income did not show a statistically significant association with vaccination status in this study, the fact that 61.75% of participants reported earning less than $100 per month suggests that financial constraints likely play a role in vaccine access. Studies from Uganda and Somalia have demonstrated that even modest costs can deter students in low-income settings from completing vaccination schedules [19,33]. Strategies such as university-sponsored vaccination drives, partnerships with public health agencies for subsidized doses, and inclusion of HBV vaccination in student health insurance plans could mitigate these barriers.

Another critical issue is the persistence of vaccine hesitancy, as evidenced by students citing fear of side effects and mistrust in vaccine quality as reasons for non-vaccination. This aligns with global trends where misinformation and lack of confidence in vaccines hinder public health efforts [34,35]. Educational campaigns debunking myths, providing transparent information on vaccine safety, and leveraging peer influence could help address these concerns. Additionally, integrating discussions on HBV vaccination and occupational safety into medical school curricula may reinforce its importance early in training. The study´s findings have important implications for policymakers and university administrators in Somaliland. Given the moderate vaccination coverage and low completion rates, institutional policies should mandate HBV vaccination as a prerequisite for clinical training, similar to policies in high-income countries [36]. Furthermore, universities should collaborate with the Ministry of Health to ensure consistent vaccine supply and establish on-campus vaccination programs. Strengthening partnerships with international organizations (e.g., Gavi, WHO) could also facilitate access to affordable vaccines, as seen in successful vaccination initiatives in developed countries [37,38].

 

 

Conclusion Up    Down

This study highlights that although medical students in Somaliland possess strong knowledge regarding HBV transmission and prevention, vaccination coverage remains suboptimal, with only two-thirds initiating the vaccine and fewer than half completing the full three-dose schedule. Structural barriers such as cost, access, and time constraints, along with departmental and academic disparities, significantly affect vaccination uptake. The finding that students in advanced academic years and those untested for HBV are less likely to be vaccinated underscores the need for enhanced awareness campaigns, routine screening, and institutional policies to ensure comprehensive HBV immunization before clinical exposure. Strengthening these measures is essential to safeguarding both students and patients in healthcare environments.

What is known about this topic

  • The hepatitis B (HB) vaccination protects against the hepatitis B virus, which can cause a dangerous liver infection that can damage the liver, induce liver failure, and even cause liver cancer;
  • Viral hepatitis exists throughout the world and is a major global public health problem affecting millions of people; hepatitis B (HBV) is the most common cause of inflammation of the liver, leading to chronic liver disease, cirrhosis, hepatocellular carcinoma, and even fulminant hepatitis.

What this study adds

  • Medical students in Somaliland possess strong knowledge regarding HBV transmission and prevention; vaccination coverage remains suboptimal;
  • Collaboration of the Universities with the Ministry of Health to ensure consistent vaccine supply and establish on-campus vaccination programs; strengthening partnerships with international organizations;
  • Strengthening these measures is essential to safeguarding both students and patients in healthcare environments.

 

 

Competing interests Up    Down

The authors declare no competing interests.

 

 

Authors' contributions Up    Down

Adnan Abdilahi Matan: conceived the study, performed the analysis, interpreted the results and drafted the manuscript. Jama Mohamed: contributed in the analysis, interpretation and reviewing of results and drafting the manuscript. Hussein Abdi Ali: contributed to revising the findings, proofreading and correcting the whole manuscript. All authors have read and agreed to the final manuscript.

 

 

Tables and figures Up    Down

Table 1: sociodemographic and academic characteristics of the study participants in Hargeisa city (Somaliland) from December 2024 to April 2025 , (N=183 students)

Table 2: knowledge of hepatitis B virus transmission and prevention among participants, in Hargeisa city (Somaliland) from December 2024 to April 2025, (N=183 students)

Table 3: multivariate analysis in factors associated with hepatitis B vaccination among students in Hargeisa city (Somaliland) from December 2024 to April 2025, (N=183 students)

Figure 1: reasons for not being vaccinated against hepatitis B among participant in Hargeisa city (Somaliland) from December 2024 to April 2025, (N=183 students)

Figure 2: number of hepatitis B doses received among students in Hargeisa city (Somaliland) from December 2024 to April 2025, (N=183 students)

 

 

References Up    Down

  1. World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Web Annex. Method for global reporting on disease burden and service coverage data for viral hepatitis B and C, 2022. WHO. 2024.

  2. Valva P. Toward Global Viral Hepatitis Eradication by 2030: Challenges and Strategies. Rev Argent Microbiol. 2023 Oct-Dec;55(4):294-295. PubMed | Google Scholar

  3. Ginzberg D, Wong RJ, Gish R. Global HBV burden: guesestimates and facts. Hepatol Int. 2018 Jul;12(4):315-329. PubMed | Google Scholar

  4. Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017 Dec;2(12):900-909. PubMed | Google Scholar

  5. Patel A, Dossaji Z, Gupta K, Roma K, Chandler T-M, Minacapelli CD et al. The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus. Gastro Hep Adv. 2023 Oct 24;3(2):139-150. PubMed | Google Scholar

  6. Sonderup MW, Spearman CW. HBV elimination in Africa-Current status and challenges. Clin Liver Dis (Hoboken). 2024 May 3;23(1):e0166. PubMed | Google Scholar

  7. Hui Z, Yu W, Fuzhen W, Liping S, Guomin Z, Jianhua L et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg Health West Pac. 2024 Sep 14;51:101193. PubMed | Google Scholar

  8. Lin J, Zhang H, Yu H, Bi X, Zhang W, Yin J et al. Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study.Front Oncol. 2022 Jun 21:12:906778. PubMed | Google Scholar

  9. Atlaw D, Sahiledengle B, Tariku Z. Hepatitis B and C virus infection among healthcare workers in Africa: a systematic review and meta-analysis. Environ Health Prev Med . 2021 Jun 2;26(1):61. PubMed | Google Scholar

  10. Lu P-J, Hung M-C, Srivastav A, Grohskopf LA, Kobayashi M, Harris AM et al. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018. MMWR Surveill Summ. 2021 May 14;70(3):1-26. PubMed | Google Scholar

  11. Ndunguru B, Wilfred D, Kapesa A, Kilonzo SD, Mirambo M, Hyera F et al. Low uptake of hepatitis B vaccination among healthcare workers in primary health facilities in Mwanza region, North-Western Tanzania. Front Public Health. 2023 Jun 2:11:1152193. PubMed | Google Scholar

  12. Bayissa L, Gela D, Boka A, Ararsa T. Hepatitis B vaccination coverage and associated factors among nurses working at health centers in Addis Ababa, Ethiopia: a cross-sectional study. BMC Nurs. 2024 Aug 28;23(1):600. PubMed | Google Scholar

  13. Frison FS, Alonzo HGA, Guerreiro I de C, Oliveira ECP de. Hepatitis B vaccination coverage and serological status among health care workers exposed to occupational biological hazards. Rev Bras Med Trab. 2023 Nov 24;21(3):e2022963. PubMed | Google Scholar

  14. Alsabaani A, Alqahtani NSS, Alqahtani SSS, Al-Lugbi JHJ, Asiri MAS, Salem SEE et al. Incidence, Knowledge, Attitude and Practice Toward Needle Stick Injury Among Health Care Workers in Abha City, Saudi Arabia. Front Public Health. 2022 Feb 14:10:771190. PubMed | Google Scholar

  15. Alshammari SA, Alrasheed SS, Alruhaimi WA, Albnyan AI, Alruhaimi B, Hajj M. Knowledge, Attitude, and Practice of Standard Infection Control Precautions Among Medical Students at King Khalid University Hospital. Cureus. 2024 Jun 20;16(6):e62768. PubMed | Google Scholar

  16. GüllüM, Türkkan A. Frequency and characteristics of occupational injuries and infections in senior medical students: a 5-year retrospective study. Discover Public Health. 2025 May 8;22(1):239. Google Scholar

  17. Hassan YSA, Hassan SA, Ahmed NR. Uptake of hepatitis B vaccination and associated factors among health sciences students, Mogadishu, Somalia. Front Public Health . 2023 Sep 14:11:1203519. PubMed | Google Scholar

  18. Ali AS, Hussein NA, Elmi EOH, Ismail AM, Abdi MM. Hepatitis B vaccination coverage and associated factors among medical students: a cross-sectional study in Bosaso, Somalia, 2021. BMC Public Health. 2023 Jun 3;23(1):1060. PubMed | Google Scholar

  19. Mohamed OMI, Mohammedali HSH, Mohamed SNA, Ahmed HAS, Mohamedsalih AAM, Abdalgani OMA et al. Knowledge, attitudes, practices, and vaccination coverage of medical students toward hepatitis B virus in North Sudan, 2023. PeerJ. 2025 Jan 2:13:e18339. PubMed | Google Scholar

  20. Abdela A, Woldu B, Haile K, Mathewos B, Deressa T. Assessment of knowledge, attitudes and practices toward prevention of hepatitis B virus infection among students of medicine and health sciences in Northwest Ethiopia. BMC Res Notes. 2016 Aug 19;9(1):410. PubMed | Google Scholar

  21. Subodh R. Thote, Gajanan C. Soyam, Dhakate MA. Hepatitis B vaccination status and knowledge, attitude, and practice of hepatitis B among medical students at a medical college in central India. Int J Community Med Public Health. 2023 Mar;10(3):1244. Google Scholar

  22. Okeke E, Ladep N, Agaba E, Malu A. Hepatitis B Vaccination Status and Needle stick Injuries among Medical Students in a Nigerian University. Niger J Med. 2008 Jul-Aug;17(3):330-2. PubMed | Google Scholar

  23. Makan N, Song E, Kramvis A. Knowledge, attitudes and practices of undergraduate health sciences students on hepatitis B vaccination at a South African university highlight the need for improvement of policies, implementation and co-ordination. S Afr Med J. 2023 May 5;113(5):39-45. PubMed | Google Scholar

  24. Tadesse S, Munshea A, Gelaw B, Peshu N, Tesfa E, Mekonnen F et al. Prevalence of hepatitis B virus infection and its associated factors in Ethiopia: a recent systematic review and meta-analysis. BMC Infect Dis. 2025 May 24;25(1):749. PubMed | Google Scholar

  25. Yazie TD, Tebeje MG. An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia. BMC Infect Dis. 2019 Oct 29;19(1):917. PubMed | Google Scholar

  26. Hussein NA, Ismail AM, Jama SS. Assessment of Hepatitis B Vaccination Status and Associated Factors among Healthcare Workers in Bosaso, Puntland, Somalia 2020. Biomed Res Int. 2022 Mar 21:2022:9074294. PubMed | Google Scholar

  27. Haile K, Timerga A, Mose A, Mekonnen Z. Hepatitis B vaccination status and associated factors among students of medicine and health sciences in Wolkite University, Southwest Ethiopia: A cross-sectional study. PLoS One. 2021 Sep 21;16(9):e0257621. PubMed | Google Scholar

  28. Naqid IA, Mosa AA, Ibrahim SV, Ibrahim NH, Hussein NR. Hepatitis B vaccination status and knowledge, attitude, and practice towards Hepatitis B virus among medical sciences students: A cross-sectional study. PLoS One. 2023 Nov 6;18(11):e0293822. PubMed | Google Scholar

  29. Adeleye OO, Oyelekan AA, Ale AO, Olaitan AO, Ayanwale A. The knowledge and reported vaccination status of hepatitis B virus amongst medical students in a Nigerian tertiary teaching hospital. Res J Heal Sci. 2019 Jun 27;7(2):109-16. Google Scholar

  30. Vo LT, Phan DQ, Tran HG, Nguyen LTP, Gyan A, Nguyen HTN et al. Hepatitis B vaccine coverage in health care students: a cross-sectional study in Vietnam. PLoS One. 2025 Mar 31;20(3):e0320860. PubMed | Google Scholar

  31. Saitoh A, Oku H, Katsuta T, Kamiya H, Ishikawa Y, Takaku M et al. Vaccination Education Deficits and Vaccine Hesitancy Among Healthcare Students in Japan: A Cross-Sectional Study. Vaccines (Basel). 2024 Nov 22;12(12):1310. PubMed | Google Scholar

  32. Machmud PB, Glasauer S, Gottschick C, Mikolajczyk R. Knowledge, Vaccination Status, and Reasons for Avoiding Vaccinations against Hepatitis B in Developing Countries: A Systematic Review. Vaccines (Basel). 2021 Jun 9;9(6):625. PubMed | Google Scholar

  33. Black S, Rappuoli R. A Crisis of Public Confidence in Vaccines. Sci Transl Med. 2010 Dec 8;2(61):61mr1. PubMed | Google Scholar

  34. Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine confidence gap.Lancet. 2011 Aug 6;378(9790):526-35. PubMed | Google Scholar

  35. Al-Busafi SA, Alwassief A. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030. Vaccines (Basel) . 2024 Mar 9;12(3):288. PubMed | Google Scholar

  36. Pagliusi S, Che Y, Dong S. The art of partnerships for vaccines. Vaccines (Basel). 2024 Mar 9;12(3):288. PubMed | Google Scholar

  37. Nunes C, McKee M, Howard N. The role of global health partnerships in vaccine equity: A scoping review. PLOS Glob Public Health. 2024 Feb 22;4(2):e0002834. PubMed | Google Scholar